Novacyt S.A. (NVYTF)
USD 0.64
(0.0%)
USD 0.64
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 46.6 Million GBP | 81.43% |
| 2022 | 25.68 Million GBP | -38.67% |
| 2021 | 41.88 Million GBP | -49.88% |
| 2020 | 83.56 Million GBP | 493.86% |
| 2019 | 14.07 Million EUR | 26.14% |
| 2018 | 11.15 Million EUR | 37.94% |
| 2017 | 8.08 Million EUR | -25.14% |
| 2016 | 10.8 Million EUR | 122.45% |
| 2015 | 4.85 Million EUR | 2.56% |
| 2014 | 4.73 Million EUR | 555.79% |
| 2013 | 722.07 Thousand EUR | -63.13% |
| 2012 | 1.95 Million EUR | -2.26% |
| 2011 | 2 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 24.83 Million GBP | -12.07% |
| 2023 Q1 | 28.24 Million GBP | 9.98% |
| 2023 Q4 | 46.6 Million GBP | 0.0% |
| 2023 FY | 46.6 Million GBP | 81.43% |
| 2022 Q2 | 33.46 Million GBP | 0.0% |
| 2022 FY | 25.68 Million GBP | -38.67% |
| 2022 Q4 | 25.68 Million GBP | -12.25% |
| 2022 Q3 | 29.27 Million GBP | -12.52% |
| 2021 FY | 41.88 Million GBP | -49.88% |
| 2021 Q4 | 41.88 Million GBP | 0.0% |
| 2021 Q2 | 43.62 Million GBP | 0.0% |
| 2020 Q2 | 26.69 Million EUR | 0.0% |
| 2020 Q4 | 83.56 Million GBP | 0.0% |
| 2020 FY | 83.56 Million GBP | 493.86% |
| 2019 FY | 14.07 Million EUR | 26.14% |
| 2019 Q4 | 16.47 Million EUR | 0.0% |
| 2019 Q2 | 14.03 Million EUR | 0.0% |
| 2018 Q4 | 11.15 Million EUR | 0.0% |
| 2018 FY | 11.15 Million EUR | 37.94% |
| 2018 Q2 | 10.37 Million EUR | 0.0% |
| 2017 Q4 | 8.08 Million EUR | 0.0% |
| 2017 FY | 8.08 Million EUR | -25.14% |
| 2017 Q2 | 10.13 Million EUR | 0.0% |
| 2016 Q4 | 10.8 Million EUR | 0.0% |
| 2016 FY | 10.8 Million EUR | 122.45% |
| 2016 Q2 | 11.05 Million EUR | 0.0% |
| 2015 Q2 | 3.61 Million EUR | 0.0% |
| 2015 FY | 4.85 Million EUR | 2.56% |
| 2015 Q4 | 4.85 Million EUR | 0.0% |
| 2014 Q4 | 4.73 Million EUR | 0.0% |
| 2014 Q2 | 4.66 Million EUR | 0.0% |
| 2014 FY | 4.73 Million EUR | 555.79% |
| 2013 FY | 722.07 Thousand EUR | -63.13% |
| 2012 FY | 1.95 Million EUR | -2.26% |
| 2011 FY | 2 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | -134.581% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -2100.209% |
| Össur hf. | 688.8 Million USD | 93.235% |
| QHSLab, Inc. | 2.05 Million USD | -2165.402% |
| Wellstar International, Inc. | 55.99 Million USD | 16.771% |
| Össur hf. | 688.8 Million USD | 93.235% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -1480.563% |
| Aurora Spine Corporation | 6.65 Million USD | -600.386% |
| BrainsWay Ltd. | 15.31 Million USD | -204.3% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -180.34% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -1.653% |
| Vivos Inc. | 245 Thousand USD | -18920.274% |
| Kelyniam Global, Inc. | 1.01 Million USD | -4500.535% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -16807.861% |
| Zecotek Photonics Inc. | 5.86 Million USD | -694.063% |
| Avitar, Inc. | 11.59 Million USD | -301.952% |
| Nanomix Corporation | 14.81 Million USD | -214.554% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -189.794% |
| Theraclion SA | 13.01 Million EUR | -258.009% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -2200.122% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -1186.889% |
| Lombard Medical, Inc. | 53.79 Million USD | 13.372% |
| ALR Technologies Inc. | 24.5 Million USD | -90.164% |
| Stratec SE | 271.97 Million USD | 82.866% |
| Vycor Medical, Inc. | 4.31 Million USD | -979.27% |
| Heart Tronics, Inc. | 1.09 Million USD | -4156.567% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 98.126% |
| VMS Rehab Systems, Inc. | 201.36 USD | -23142744.656% |
| NewCardio, Inc. | 6.01 Million USD | -675.04% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -751.149% |
| Ingen Technologies, Inc. | 5.7 Million USD | -716.184% |
| Odyssey Group International, Inc. | 6.61 Million USD | -604.815% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -1802.208% |
| Wellness Center USA, Inc. | 5.12 Million USD | -809.419% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 28.956% |
| IR-Med Inc. | 634 Thousand USD | -7250.226% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -750.906% |
| Polarean Imaging plc | 2.58 Million USD | -1705.841% |
| United American Healthcare Corporation | 119 Thousand USD | -39060.027% |
| ECGI Holdings, Inc. | 11.94 Million USD | -290.277% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -1875.611% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -3419.713% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -3121.962% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -6777.115% |
| Urologix, Inc. | 12.64 Million USD | -268.558% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -763.601% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -449.374% |
| SS Innovations International, Inc. | 11.18 Million USD | -316.779% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -8769.735% |
| Smith & Nephew plc | 4.76 Billion USD | 99.022% |
| NIOX Group Plc | 9.8 Million USD | -375.413% |
| Fuse Medical, Inc. | 15.11 Million USD | -208.407% |
| Broncus Holding Corporation | 10.43 Million USD | -346.699% |
| Brain Scientific Inc. | 7.42 Million USD | -527.497% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -37.857% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -5768.473% |